MSB 5.24% $1.11 mesoblast limited

Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-320

  1. 7,295 Posts.
    lightbulb Created with Sketch. 1891
    This commercial partnership can benefit all stem cell companies, legitimising stem cell science and technology in both the general public's and regulators' (plural) eyes. Other companies will benefit from this, some people are too short-sighted to see this.

    @Sector is (allegedly) a Top 20 holder in CYP - of course he doesn't want to see the alternative view. This dude is wearing out keyboards on the CYP threads re MSB... biggrin.png

    Today's announcement is very positive for MSB, and there are some serious SP catalysts potentially just around the corner.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.11
Change
0.055(5.24%)
Mkt cap ! $1.261B
Open High Low Value Volume
$1.05 $1.13 $1.04 $6.781M 6.207M

Buyers (Bids)

No. Vol. Price($)
3 43856 $1.11
 

Sellers (Offers)

Price($) Vol. No.
$1.11 66000 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.